(c) 2024 PillSync.com

memantine 5 mg

1 INDICATIONS AND USAGE Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. (1)

Major Pharmaceuticals


5 months ago OVAL ORANGE 596 RDY memantine 5 mg

OVAL ORANGE 596 RDY

5 months ago OVAL ORANGE 596 RDY memantine 5 mg

596 RDY OVAL ORANGE

16 HOW SUPPLIED/STORAGE AND HANDLING

MEMANTINE hydrochloride tablets USP, 5 mg are orange colored, capsule shaped, biconvex, film coated tablets debossed with ‘RDY’ on one side and ‘596’ on other side. Carton of 50 tablets (10 tablets each blister pack x 5), NDC 0904-6505-06 Carton of 100 tablets (10 tablets each blister pack x 10), NDC 0904-6505-61

MEMANTINE hydrochloride tablets USP, 10 mg are grey colored, capsule shaped, biconvex, film coated tablets debossed with ‘RDY’ on one side and ‘597’ on other side. Carton of 50 tablets (10 tablets each blister pack x 5), NDC 0904-6506-06 Carton of 100 tablets (10 tablets each blister pack x 10), NDC 0904-6506-61 Store at 20°-25°C (68°-77°F); [See USP Controlled Room Temperature.]


More pills like OVAL 596 RDY

Related Pills

memantine 5 mg

Major Pharmaceuticals












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site